Salarius Pharmaceuticals Inc

NASDAQ:SLRX   9:34:03 AM EDT
0.82
+0.01 (+1.46%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)12.04M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.28 Million
Adjusted EPS-$0.06
See more estimates
10-Day MA$0.87
50-Day MA$1.09
200-Day MA$1.19
See more pivots

Salarius Pharmaceuticals Inc Stock, NASDAQ:SLRX

2450 Holcombe Boulevard, Suite X, Houston, Texas 77021
United States of America
Phone: +1.832.834.6992
Number of Employees: 9
http://salariuspharma.com/

Description

Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company. The firm focuses on the development of Salarius� clinical pipeline, which targets rare, orphan cancers and cancers with a high unmet need. The company was founded in 2014 and is headquartered in Houston, TX.